普通病房低氧性COVID-19患者俯卧位与常规治疗的随机对照试验
这项多中心随机临床试验纳入268例在普通病房需要氧疗的COVID-19患者,随机分为清醒俯卧位联合常规治疗组(N=135)与单纯常规治疗组(N=132)。随机化后72小时内每日俯卧位中位时间为90分钟(IQR 30-133)。28天内无创通气或插管或死亡比例在俯卧位组为14.1%(19/135),常规治疗组为12.9%(17/132),校正分层因素的优势比(aOR)为0.43(95%CI 0.14-1.35)。插管或死亡、插管等次要结局在俯卧位组较低,全人群及入组时SpO2≥95%亚组中均见较低aOR,但复合主要终点未降低。
要点
- 普通病房COVID-19低氧患者清醒俯卧位联合常规治疗未降低28天内无创通气或插管或死亡复合终点(14.1% vs 12.9%,aOR 0.43,95%CI 0.14-1.35)。
- 随机化后72小时内每日俯卧位中位时间仅90分钟(IQR 30-133),俯卧位依从时间有限。
- 次要结局插管率(aOR 0.11,95%CI 0.01-0.89)和插管或死亡(aOR 0.09,95%CI 0.01-0.76)在俯卧位组较低。
- 入组时SpO2≥95%预设亚组中,插管(aOR 0.11,95%CI 0.01-0.90)和插管或死亡(aOR 0.09,95%CI 0.03-0.27)在俯卧位组较低。
适用人群与场景
- 在普通病房住院、需要氧疗的COVID-19低氧血症患者。
- 多中心随机临床试验纳入268例患者,随机分为清醒俯卧位联合常规治疗组(N=135)和单纯常规治疗组(N=132)。
处置流程与药物剂量
- 清醒俯卧位联合常规治疗:随机化后72小时内每日俯卧位中位时间为90分钟(IQR 30-133)。
- 对照组接受单纯常规治疗。
研究设计与关键结果
- 研究类型:多中心随机临床试验,纳入268例普通病房COVID-19低氧血症患者,随机分为清醒俯卧位联合常规治疗组(N=135)与单纯常规治疗组(N=132)。
- 主要终点:28天内接受无创通气或插管或死亡的比例,俯卧位组14.1%(19/135) vs 常规治疗组12.9%(17/132),校正分层因素的优势比(aOR)0.43(95%CI 0.14-1.35)。
- 次要终点插管率:俯卧位组低于常规治疗组,aOR 0.11(95%CI 0.01-0.89)。
- 次要终点插管或死亡:俯卧位组低于常规治疗组,aOR 0.09(95%CI 0.01-0.76)。
- 预设亚组(入组时SpO2≥95%):插管aOR 0.11(95%CI 0.01-0.90),插管或死亡aOR 0.09(95%CI 0.03-0.27),俯卧位组较低。
- 随机化后72小时内每日俯卧位中位时间为90分钟(IQR 30-133)。
证据类型、等级与局限
- 证据类型:多中心随机临床试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在普通病房COVID-19低氧血症患者中,清醒俯卧位联合常规治疗未降低28天内无创通气或插管或死亡复合终点。
- 原文结论未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Benefit of early awake prone positioning for COVID-19 patients hospitalised in medical wards and who need oxygen therapy remains to be demonstrated. The question was considered at the time of COVID-19 pandemic to avoid overloading the intensive care units. We aimed to determine whether prone position plus usual care could reduce the rate of non-invasive ventilation (NIV) or intubation or death as compared to usual care alone.
METHODS: In this multicentre randomised clinical trial, 268 patients were randomly assigned to awake prone position plus usual care (N = 135) or usual care alone (N = 132). The primary outcome was the proportion of patients who underwent NIV or intubation or died within 28 days. Main secondary outcomes included the rates of NIV, of intubation or death, within 28 days.
RESULTS: Median time spent each day in the prone position within 72 h of randomisation was 90 min (IQR 30-133). The proportion of NIV or intubation or death within 28 days was 14.1% (19/135) in the prone position group and 12.9% (17/132) in the usual care group [odds ratio adjusted for stratification (aOR) 0.43; 95% confidence interval (CI) 0.14-1.35]. The probability of intubation, or intubation or death (secondary outcomes) was lower in the prone position group than in the usual care group (aOR 0.11; 95% CI 0.01-0.89 and aOR 0.09; 95% CI 0.01-0.76, respectively) in the whole study population and in the prespecified subgroup of patients with SpO2 ≥ 95% on inclusion (aOR 0.11; 95% CI 0.01-0.90, and aOR 0.09; 95% CI 0.03-0.27, respectively).
CONCLUSIONS: Awake prone position plus usual care in COVID-19 patients in medical wards did not decrease the composite outcome of need for NIV or intubation or death. Trial registration ClinicalTrials.gov Identifier: NCT04363463 . Registered 27 April 2020.
参考来源
- Nay MA, Hindre R, Perrin C, et al. Prone position versus usual care in hypoxemic COVID-19 patients in medical wards: a randomised controlled trial. Crit Care. 2023. PMID: 37330512. doi:10.1186/s13054-023-04529-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。